home / open_comments / documents

documents: FDA-2026-N-9703-0001

Federal regulatory documents currently open for public comment. ⚠ Derive comment deadlines from comment_end_datetime converted to America/New_York, never from comment_end_date, which is mid-correction and may be one day late (DataDawn queue #498).

Data license: Public Domain (U.S. Government data) · Data source: Regulations.gov API (General Services Administration)

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date comment_end_datetime perpetual_docket last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-9703-0001 FDA FDA-2026-N-9703 Salerno Pharmaceuticals; Proposal To Withdraw Approval of a New Drug Application for Flolipid Suspension, 20 Milligrams/5 Milliliters and 40 Milligrams/5 Milliliters; Opportunity for a Hearing Notice Notice of Opportunity of Hearing 2026-11-18 2026 11 2026-11-18 2027-01-19 2027-01-20 04:59:59 0 2026-11-18 19:49:27 2026-23413 1 0 09000064b97280d0
Powered by Datasette · Queries took 1.487ms · Data license: Public Domain (U.S. Government data) · Data source: Regulations.gov API (General Services Administration) · Privacy